Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Active not recruiting 1

Sponsor Class

NETWORK 1

Study Type

Interventional 1

Sponsor

Cancer Type

CNS 1

Conditions

Prostatic Neoplasms 15Carcinoma, Non-Small-Cell Lung 9Uterine Cervical Neoplasms 7Colonic Neoplasms 6Breast Neoplasms 5Uterine Cervical Dysplasia 4Urinary Bladder Neoplasms 4Papillomavirus Infections 3Neuroblastoma 3Melanoma 3Lung Neoplasms 3Leukemia, Myeloid, Acute 3Esophageal Neoplasms 3Brain Neoplasms 3Anus Neoplasms 3Triple Negative Breast Neoplasms 2Thyroid Neoplasms 2Squamous Intraepithelial Lesions 2Rectal Neoplasms 2Precancerous Conditions 2Oropharyngeal Neoplasms 2Neoplasms 2Mouth Neoplasms 2Lymphoma, Large B-Cell, Diffuse 2Liver Neoplasms 2Leukemia, Myelomonocytic, Acute 2Leukemia, Monocytic, Acute 2Leukemia, Megakaryoblastic, Acute 2Leukemia, Erythroblastic, Acute 2HIV Infections 2

Interventions

Cyclophosphamide 8dinutuximab 7Magnetic Resonance Spectroscopy 7Topotecan 6Doxorubicin 6sargramostim 5Vincristine 5Stem Cell Transplantation 5Radiation 5Platinum 5Melphalan 5Isotretinoin 5Colony-Stimulating Factors 5Cisplatin 5Biopsy 51,2-diaminocyclohexaneplatinum II citrate 5Temozolomide 4Specimen Handling 4Irinotecan 4Etoposide 4Congresses as Topic 4Carboplatin 4Thiotepa 3Busulfan 33-Iodobenzylguanidine 3etoposide phosphate 2Razoxane 2Dexrazoxane 2temsirolimus 1lorlatinib 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Interventional × Ganglioneuroblastoma × Watchful Waiting × Clear all
NCT02176967 2026-05-05

Response and Biology-Based Risk Factor-Guided Therapy in Treating Younger Patients With Non-high Risk Neuroblastoma

Children's Oncology Group

Phase 3 Active not recruiting
621 enrolled
CNS

Neuroblastoma, Ganglioneuroblastoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡